The NHS Federated Data Platform

The Platform Hypothesis at Scale

The NHS Federated Data Platform (FDP) is a £480m, 7-year contract awarded in November 2023 to a consortium led by Palantir Technologies UK, to create a NHS-wide data platform connecting health information across NHS organisations. It is the largest single test of the platform model in NHS history.

As of May 2025, fewer than a third of NHS hospital trusts are actively using it. The adoption gap is not evidence that the platform concept is wrong — it is evidence of what happens when a platform is procured top-down without adequate sociotechnical engagement. The barriers are not technical; Palantir's Foundry platform is technically capable and has received a Green NISTA rating. The barriers are organisational, financial and governance-related.

Contract and Governance

The contract was procured via a competitive open tender with the formal contract beginning March 2024. The consortium comprises Palantir Technologies UK (lead), Accenture, PWC, Carnall Farrar, and NECS. The contract structure is incremental: NHS England committed to an initial three-year term (to March 2027), extendable to a potential maximum of March 2031. The initial period comes up for review in March 2027. In July 2025 the FDP received a Green NISTA rating — one of only 14% of government major programmes to achieve this.

Data Governance Controversy

Public and political concern has centred on Palantir's relationship to NHS patient data. The contractual protections are explicit: Palantir is a processor under data protection law only, not a controller; it cannot commercialise or market NHS data; it cannot use NHS data to train AI models; all data is stored and processed within the UK. However, in May 2026 NHS England confirmed that Palantir staff can obtain a new "admin" role giving access to patient data — reinforcing the political sensitivity of having a US technology company with administrative access to NHS patient records.

Implications for the Platform Model

The FDP does not refute the platform hypothesis — it illustrates the conditions under which a technically sound platform fails to generate adoption at scale. Mapped against the Complexity Challenges: Context (215 hospital trusts at very different levels of digital readiness cannot be addressed without significant local engagement, which was not built into the procurement model); Collaboration (the POTE Framework argues for co-design as a condition of sustainable adoption; the FDP was procured as a supply-side solution); Sustainability (data security standards failure in nearly a third of connected trusts means the platform cannot deliver the 5× return the NHS projects if adoption remains partial).

Open Questions

What does the renewal decision in March 2027 depend on, and what evidence is NHS England building toward it? Does the FDP's architecture support person-centred combinatorial care, or is it primarily an operational/analytical platform for NHS internal use? The Green NISTA rating addresses governance process, not outcome delivery — the March 2027 decision will require evidence of clinical and operational benefit at scale.